|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
A method for treating a disease using a specific compound.
|
|
gptkbp:applicationDate
|
1990-05-15
|
|
gptkbp:applicationNumber
|
07/512,345
|
|
gptkbp:applicationType
|
non-provisional
|
|
gptkbp:assignee
|
gptkb:Acme_Corporation
|
|
gptkbp:assigneeCountry
|
gptkb:USA
|
|
gptkbp:assigneeType
|
corporation
|
|
gptkbp:citedBy
|
gptkb:US_50,000,040_B2
|
|
gptkbp:claims
|
10
|
|
gptkbp:classification
|
A61K
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
2011-05-15
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:filingDate
|
1990-05-15
|
|
gptkbp:grantDate
|
1991-03-26
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 50,000,039 B2
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:inventorCountry
|
gptkb:USA
|
|
gptkbp:inventorResidence
|
gptkb:California
|
|
gptkbp:issueDate
|
1991-03-26
|
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
|
gptkbp:language
|
English
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:material
|
compound X
|
|
gptkbp:nonPatentCitation
|
3
|
|
gptkbp:patentCitation
|
5
|
|
gptkbp:patentClassification
|
pharmaceutical composition
|
|
gptkbp:patentFamily
|
US_50,000,039
|
|
gptkbp:patentField
|
medical treatment
|
|
gptkbp:patentLink
|
https://patents.google.com/patent/US50000039B2
|
|
gptkbp:patentLitigation
|
none
|
|
gptkbp:patentNumber
|
50,000,039
|
|
gptkbp:patentOwner
|
gptkb:Acme_Corporation
|
|
gptkbp:patentStatus
|
gptkb:USA
active
|
|
gptkbp:patentType
|
Utility Patent
utility
|
|
gptkbp:priorityDate
|
1989-05-15
|
|
gptkbp:publicationNumber
|
US_50,000,039_A1
|
|
gptkbp:relatedPatent
|
gptkb:US_50,000,040_B2
|
|
gptkbp:relatedTo
|
disease treatment
|
|
gptkbp:research_areas
|
treating condition Y
|
|
gptkbp:researchAreas
|
biotechnology
|
|
gptkbp:researchField
|
medical research
|
|
gptkbp:status
|
active
|
|
gptkbp:technique
|
administering compound X
|
|
gptkbp:title
|
Method for treating a disease
|